New research shows that reducing dietary protein may significantly lower liver cancer risk or slow its progression in people ...

Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become ...

People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple ...

Liver cancer often develops in individuals with chronic liver disease, with hepatocellular carcinoma (HCC) and cholangiocarcinoma as the main types. HCC is commonly associated with hepatitis B or C, ...

Margot got the news in her early 20s: "You have liver cancer," her doctors told her. Specifically, Margot had a form of liver cancer known as fibrolamellar carcinoma, a diagnosis with deadly prospects ...

Salk Institute scientists discovered that bile acids in the liver can weaken immune cell function, making immunotherapy less effective against liver cancer. They pinpointed specific bile acids that ...

Study suggests that persistently activated ATF6α is a tumor driver, a potential stratification marker for immunotherapy response, and a therapeutic target for HCC.

Immunotherapy-based combinations have rapidly replaced tyrosine kinase inhibitors as first-line treatment for advanced hepatocellular carcinoma, reshaping real-world practice over the past decade. In ...

The liver is an extremely sensitive organ. It filters blood, eliminates toxins and creates bile to digest food; without a functioning liver, a person will die. Its sensitive nature, however, makes it ...

World Cancer Day highlights the shared impact of cancer and the importance of staying engaged and connected across the cancer ...